DiBrino M, Parker K C, Margulies D H, Shiloach J, Turner R V, Biddison W E, Coligan J E
Laboratory of Molecular Structure, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Biochemistry. 1995 Aug 15;34(32):10130-8. doi: 10.1021/bi00032a005.
Most peptides that bind to a particular MHC class I molecule share amino acid residues that are thought to physically "anchor" the peptide to polymorphic pockets within the class I binding site. Sequence analysis of endogenous peptides bound to HLA-B44 revealed two potential dominant anchor residues: Glu at P2 and Tyr, or occasionally Phe, at P9. In vitro assembly assays employing synthetic peptides and recombinant HLA-B44 produced by Escherichia coli revealed that an acidic amino acid at P2 was necessary for promoting stable peptide binding to HLA-B44. Surprisingly, although Tyr was almost exclusively found at P9 of the endogenous peptide sequences, a wide variety of amino acid residues such as Leu, Ala, Arg, Lys, His, and Phe could be tolerated at this position. Using this information, we identified antigenic peptides from the influenza virus components nonstructural protein 1 and nucleoprotein that are presented by HLA-B44 to antiinfluenza type A cytotoxic T lymphocytes. In addition, cytotoxic T lymphocytes induced by these antigenic peptides were shown to be capable of recognizing endogenously processed peptides from influenza-infected cells, indicating a potential use for these peptides in vaccine development. Finally, molecular models were created to investigate the possible ways in which the anchor residues might function to stabilize the binding of peptides to HLA-B44, and these models indicate that the acidic residue at P2 most likely interacts primarily with Lys 45 of the HLA-B44 heavy chain and makes additional contacts with Ser 67 and Tyr 9.
大多数与特定I类主要组织相容性复合体(MHC)分子结合的肽段都共享一些氨基酸残基,这些残基被认为在物理上可将肽段“锚定”于I类结合位点内的多态性口袋中。对与HLA - B44结合的内源性肽段进行序列分析,发现了两个潜在的主要锚定残基:P2位的谷氨酸(Glu)以及P9位的酪氨酸(Tyr),偶尔也会是苯丙氨酸(Phe)。利用合成肽段和大肠杆菌产生的重组HLA - B44进行的体外组装试验表明,P2位的酸性氨基酸对于促进肽段与HLA - B44的稳定结合是必需的。令人惊讶的是,尽管在内源性肽段序列的P9位几乎只发现酪氨酸,但在该位置可以耐受多种氨基酸残基,如亮氨酸(Leu)、丙氨酸(Ala)、精氨酸(Arg)、赖氨酸(Lys)、组氨酸(His)和苯丙氨酸。利用这些信息,我们从甲型流感病毒的非结构蛋白1和核蛋白成分中鉴定出了由HLA - B44呈递给抗甲型流感细胞毒性T淋巴细胞的抗原肽段。此外,由这些抗原肽段诱导产生的细胞毒性T淋巴细胞能够识别来自流感感染细胞的内源性加工肽段,这表明这些肽段在疫苗开发中具有潜在用途。最后,构建了分子模型以研究锚定残基可能稳定肽段与HLA - B44结合的方式,这些模型表明P2位的酸性残基最有可能主要与HLA - B44重链的赖氨酸45相互作用,并与丝氨酸67和酪氨酸9形成额外的接触。